SEC ownership of Innoviva, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001080014.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001080014
Issuer location
Burlingame, CA

Ownership snapshot

Top shareholders of Innoviva, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
13F 13D/G Lead comparable stake: 14% 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 14%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 14%
DIMENSIONAL FUND ADVISORS LP 5.8%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.8%
RENAISSANCE TECHNOLOGIES LLC 5.6%
VANGUARD CAPITAL MANAGEMENT LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
14%
from 13D/G
$262,418,797
11,555,209 shares
30 Jun 2026
DIMENSIONAL FUND ADVISORS LP
13F 13D/G
Company
5.8%
from 13D/G
$102,062,559
4,494,053 shares
30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
5.8%
$99,911,868
4,288,063 shares
$0 31 Mar 2026
RENAISSANCE TECHNOLOGIES LLC
13F 13D/G
Company
5.6%
from 13D/G
$91,669,642
4,036,532 shares
30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5%
$82,418,116
3,704,185 shares
$0 30 Jun 2026
Sarissa Capital Management LP
13D/G 13F
Company
4.7%
$54,515,484
2,966,022 shares
-$41,743,535 13 Mar 2025
FRANKLIN RESOURCES INC
13D/G 13F
Company
4.5%
$56,812,873
2,827,918 shares
-$32,232,054 30 Jun 2025
BANK OF NOVA SCOTIA
13D/G
3.4%
$39,766,841
2,179,005 shares
-$25,674,556 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-17 of 17 reporting-owner rows connected to Innoviva, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
17
Largest Forms 3/4/5 holder
Alexander J. Denner
Net 12M change
$0
Latest report
20 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Alexander J. Denner 10%+ Owner $99,127,497 Filing P/S 04 Mar 2025
Pavel Raifeld Chief Executive Officer, Director $6,467,785 Median 20 Aug 2026
Jules Haimovitz Director $3,557,723 Mixed 04 May 2026
Sarah J. Schlesinger Director $3,273,463 Mixed 04 May 2026
Mark DiPaolo Director $3,273,463 Mixed 04 May 2026
George Bickerstaff Director $2,202,172 Mixed 25 Apr 2022
Stephen Basso Chief Financial Officer $1,998,775 Median 20 Aug 2026
Kostas D. Odysseas Director $1,977,941 Mixed 17 Jun 2024
Marianne Zhen Chief Accounting Officer $1,280,594 Median 20 Aug 2026
Derek A. Small Director $1,049,315 Mixed 04 May 2026
Deborah Birx Director $946,693 Mixed 22 May 2023
Sapna Srivastava Director $711,268 Mixed 17 Jun 2024
Matthew Ronsheim Officer $653,426 Mixed 20 May 2024
Josephine Linden Director $354,020 Mixed 18 May 2026
Larry G. Edwards CEO of La Jolla Pharmaceutical Mixed 22 Aug 2022
Margaret Koziel Chief Medical Officer Mixed 31 Jul 2023
GSK plc 10%+ Owner Mixed 20 May 2021

Recent insider transactions for Innoviva, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Marianne Zhen INVA Common Stock Tax liability -1.96% -1,127 56,389 20 Aug 2026 Direct
Stephen Basso INVA Common Stock Tax liability -0.63% -558 88,013 20 Aug 2026 Direct
Pavel Raifeld INVA Common Stock Tax liability -0.4% -1,130 284,799 20 Aug 2026 Direct
Stephen Basso INVA Common Stock Tax liability -0.63% -559 88,571 20 May 2026 Direct
Pavel Raifeld INVA Common Stock Tax liability -0.39% -1,130 285,929 20 May 2026 Direct
Marianne Zhen INVA Common Stock Tax liability -1.92% -1,127 57,516 20 May 2026 Direct
Josephine Linden INVA Common Stock Award 15,194 15,194 18 May 2026 Direct
Josephine Linden INVA Non-statutory Stock Option Award 9,166 9,166 18 May 2026 Direct
Stephen Basso INVA Common Stock Award 1.28% 1,123 89,130 15 May 2026 Direct
Pavel Raifeld INVA Common Stock Award 0.39% 1,123 287,059 15 May 2026 Direct
Mark DiPaolo INVA Common Stock Award 7.49% 9,786 140,492 04 May 2026 Direct
Mark DiPaolo INVA Non-statutory Stock Option Award 10,000 10,000 04 May 2026 Direct
Pavel Raifeld INVA Common Stock Award 79.5% 126,646 285,936 04 May 2026 Direct
Pavel Raifeld INVA Non-statutory Stock Option Award 312,500 312,500 04 May 2026 Direct
Marianne Zhen INVA Common Stock Award 27.8% 12,766 58,643 04 May 2026 Direct
Marianne Zhen INVA Non-statutory Stock Option Award 31,500 31,500 04 May 2026 Direct
Sarah J. Schlesinger INVA Common Stock Award 7.49% 9,786 140,492 04 May 2026 Direct
Sarah J. Schlesinger INVA Non-statutory Stock Option Award 10,000 10,000 04 May 2026 Direct
Stephen Basso INVA Common Stock Award 76% 37,994 88,007 04 May 2026 Direct
Stephen Basso INVA Non-statutory Stock Option Award 93,750 93,750 04 May 2026 Direct
Derek A. Small INVA Common Stock Award 27.8% 9,786 45,035 04 May 2026 Direct
Derek A. Small INVA Non-statutory Stock Option Award 10,000 10,000 04 May 2026 Direct
Jules Haimovitz INVA Common Stock Award 6.85% 9,786 152,692 04 May 2026 Direct
Jules Haimovitz INVA Non-statutory Stock Option Award 10,000 10,000 04 May 2026 Direct
Stephen Basso INVA Common Stock Tax liability -2.43% -1,244 50,013 20 Feb 2026 Direct
Pavel Raifeld INVA Common Stock Tax liability -1.84% -2,986 159,290 20 Feb 2026 Direct
Marianne Zhen INVA Common Stock Tax liability -5.09% -2,460 45,877 20 Feb 2026 Direct
Stephen Basso INVA Common Stock Tax liability -0.46% -237 51,257 20 Nov 2025 Direct
Marianne Zhen INVA Common Stock Tax liability -2.01% -992 48,337 20 Nov 2025 Direct
Stephen Basso INVA Common Stock Award 1.19% 604 51,494 15 Nov 2025 Direct
Stephen Basso INVA Common Stock Award 118.6% 27,609 50,890 03 Nov 2025 Direct
Pavel Raifeld INVA Common Stock Award 213% 110,436 162,276 03 Nov 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .